This inventor holds 11 USPTO granted patents and 2 EPO patents. Top assignees: Lek Pharmaceuticals D.d., Lek Pharmaceutical and Chemical Company D.d.. Active years: 2003-2006.
Company Filing History:
Years Active: 2003-2006
Sure, here is an article about inventor Zlatko Pflaum:
Title: Innovator Spotlight: Zlatko Pflaum Shaping the Future of Pharmaceutical Treatments
Introduction:
In the realm of pharmaceutical innovations, Zlatko Pflaum stands out as a pioneering inventor, hailing from Domžale, Slovenia. With a remarkable portfolio of 11 patents, his groundbreaking contributions in the field of antihypercholesterolemic agents have significantly impacted the landscape of medical treatments.
Latest Patents:
Zlatko Pflaum's latest patents revolve around the development of crystalline forms of the sodium salt of pravastatin, a vital component in the fight against hypercholesterolemia and hyperlipidemia. These innovations not only include the creation of novel pharmaceutical formulations containing key compounds like lovastatin and simvastatin but also encompass the methods for their preparation and isolation, paving the way for more effective treatment options.
Career Highlights:
Having worked with esteemed organizations such as Lek Pharmaceuticals D.d. and Lek Pharmaceutical and Chemical Company D.d., Zlatko Pflaum has demonstrated his expertise in pharmaceutical research and development. His dedication to advancing medical science through innovative solutions has earned him a commendable reputation within the industry.
Collaborations:
Throughout his career, Zlatko Pflaum has collaborated closely with accomplished professionals in the field, including notable coworkers like Mateja Salobir and Zdenka Jerala. The synergy created by such partnerships has been instrumental in driving forward his pioneering research initiatives and enhancing the efficacy of pharmaceutical treatments.
Conclusion:
In conclusion, Zlatko Pflaum's inventive spirit and unwavering commitment to excellence have positioned him as a key figure in the realm of pharmaceutical innovations. His relentless pursuit of novel solutions for combating hypercholesterolemia and hyperlipidemia exemplifies his profound impact on the healthcare industry, making him a luminary in the field of medicinal advancements.